| RS2112094320 |
DNAJC21
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2112100020 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2112100189 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2112100217 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2112100310 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2112106462 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112106537 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112106551 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS2112106614 |
MSH3
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2112106687 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112106713 |
MSH3
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 4, Hereditary cancer-predisposing syndrome |
| RS2112108878 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS2112108977 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2112118327 |
MSH3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS2112118578 |
MSH3
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS2112128589 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Hereditary cancer-predisposing syndrome |
| RS2112128704 |
CWC27
|
Health Risk |
Pathogenic |
— |
| RS2112128764 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112128814 |
MSH3
|
Health Risk |
Pathogenic |
— |
| RS2112129385 |
HEXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Sandhoff disease, Sandhoff disease |
| RS2112135868 |
HEXB
|
Health Risk |
Pathogenic/Likely pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112150100 |
CERT1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 34 |
| RS2112156345 |
HEXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Sandhoff disease, Sandhoff disease |
| RS2112156393 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112161191 |
CWC27
|
Health Risk |
Pathogenic |
— |
| RS2112169750 |
CWC27
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia-retinitis pigmentosa syndrome, Metaphyseal chondrodysplasia-retinitis pigmentosa syndrome |
| RS2112171738 |
HEXB
|
Health Risk |
Likely pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112171931 |
HEXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Sandhoff disease, Sandhoff disease |
| RS2112174996 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112175171 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112175206 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112175228 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112177114 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112177192 |
HEXB
|
Health Risk |
Likely pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112180571 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112180614 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112180705 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112180739 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112180944 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112180987 |
HEXB
|
Health Risk |
Pathogenic/Likely pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112186316 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112188865 |
HEXB
|
Health Risk |
Likely pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112189087 |
HEXB
|
Health Risk |
Likely pathogenic |
Sandhoff disease, Sandhoff disease |
| RS2112197421 |
PIK3R1
|
Health Risk |
Pathogenic |
SHORT syndrome, SHORT syndrome |
| RS2112207891 |
CWC27
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia-retinitis pigmentosa syndrome, Metaphyseal chondrodysplasia-retinitis pigmentosa syndrome |
| RS2112211996 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS2112214898 |
CWC27
|
Health Risk |
Pathogenic |
— |
| RS2112222433 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112223281 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS2112223340 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112223349 |
RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112231793 |
MAP1B
|
Health Risk |
Likely pathogenic |
Periventricular nodular heterotopia 9, Periventricular nodular heterotopia 9 |
| RS2112237964 |
SKIC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Trichohepatoenteric syndrome 1, Trichohepatoenteric syndrome 1 |
| RS2112238696 |
MAP1B
|
Health Risk |
Pathogenic |
— |
| RS2112251301 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112251855 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112253467 |
PIK3R1
|
Health Risk |
Pathogenic |
Immunodeficiency 36 with lymphoproliferation, SHORT syndrome |
| RS2112260281 |
SKIC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Trichohepatoenteric syndrome, Trichohepatoenteric syndrome |
| RS2112261986 |
PIK3R1
|
Health Risk |
Likely pathogenic |
Immunodeficiency 36 with lymphoproliferation, SHORT syndrome |
| RS2112275093 |
ZSWIM6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2112276825 |
PIK3R1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2112277098 |
PIK3R1
|
Health Risk |
Likely pathogenic |
CLOVES syndrome, CLOVES syndrome |
| RS2112278418 |
PIK3R1
|
Health Risk |
Likely pathogenic |
PIK3R1-related disorder, PIK3R1-related disorder |
| RS2112279054 |
OXCT1
|
Health Risk |
Pathogenic |
Succinyl-CoA acetoacetate transferase deficiency, Succinyl-CoA acetoacetate transferase deficiency |
| RS2112279505 |
OXCT1
|
Health Risk |
Pathogenic |
Succinyl-CoA acetoacetate transferase deficiency, Succinyl-CoA acetoacetate transferase deficiency |
| RS2112294273 |
ZSWIM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with movement abnormalities, abnormal gait |
| RS2112300864 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2112308448 |
SKIC3
|
Health Risk |
Pathogenic |
Trichohepatoenteric syndrome 1, Trichohepatoenteric syndrome 1 |
| RS2112308481 |
SKIC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Trichohepatoenteric syndrome 1, Trichohepatoenteric syndrome 1 |
| RS2112308599 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112308910 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112309156 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112320552 |
SKIC3
|
Health Risk |
Likely pathogenic |
Trichohepatoenteric syndrome 1, SKIC3-related disorder |
| RS2112327948 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2112328709 |
MCCC2
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112329234 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112331217 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2112339517 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2112343388 |
CWC27
|
Health Risk |
Pathogenic |
— |
| RS2112344385 |
SKIC3
|
Health Risk |
Likely pathogenic |
Trichohepatoenteric syndrome, Trichohepatoenteric syndrome |
| RS2112344793 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2112346642 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2112357253 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2112365844 |
RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112366112 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112366158 |
RASA1
|
Health Risk |
Pathogenic |
— |
| RS2112369549 |
RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112369561 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2112376248 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS2112377756 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2112393633 |
LIFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Stuve-Wiedemann syndrome, Congenital anomaly of kidney and urinary tract |
| RS2112412398 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112416721 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2112416850 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2112419752 |
PCSK1
|
Health Risk |
Pathogenic |
Obesity due to prohormone convertase I deficiency, Obesity due to prohormone convertase I deficiency |
| RS2112421532 |
RASA1
|
Health Risk |
Pathogenic |
— |
| RS2112421707 |
RASA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS2112422226 |
PCSK1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2112427637 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS2112430367 |
LIFR
|
Health Risk |
Pathogenic |
— |